Currently, there are six FDA approved weight loss medications. They include three GLP-1 receptor agonists -- liraglutide ...

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist the treatment. The answer to this antimicrobial resistance, which the ...

Popular brands like Prilosec, Nexium, and Prevacid are often taken daily to reduce stomach acid and help manage conditions ...

Tremfya is also approved to treat patients with plaque psoriasis, active psoriatic arthritis and ulcerative colitis and is ...

Pharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 millionCash and cash ...

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...

Most of ProKidney's money went toward R&D as it attempts to get its first-in-class cellular therapy for Chronic Kidney ...

Regulators are expected to make a decision in the third quarter of 2025 on Kerendia to treat patients with heart failure with ...

Bayer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its kidney-disease drug Kerendia in certain people with heart failure.

A drug already used to treat people who have diabetes and/or chronic kidney disease could have added heart disease benefits, ...